Market Closed -
Nasdaq Stockholm
04:43:18 31/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
1.99
SEK
|
+2.58%
|
|
-0.50%
|
+2.05%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
56.83
|
54.94
|
28.42
|
108.6
|
Enterprise Value (EV)
1 |
40.19
|
32
|
-11.67
|
87.01
|
P/E ratio
|
-6.35
x
|
-5.47
x
|
-3.4
x
|
-12.1
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
19.4
x
|
4.95
x
|
2.92
x
|
11.1
x
|
EV / Revenue
|
13.7
x
|
2.88
x
|
-1.2
x
|
8.86
x
|
EV / EBITDA
|
-5.99
x
|
-4.82
x
|
1.22
x
|
-10.6
x
|
EV / FCF
|
-70,12,401
x
|
-21,40,118
x
|
7,98,033
x
|
-24,21,577
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
-0%
|
Price to Book
|
2.41
x
|
1.35
x
|
1.11
x
|
1.37
x
|
Nbr of stocks (in thousands)
|
10,525
|
21,050
|
21,050
|
55,686
|
Reference price
2 |
5.400
|
2.610
|
1.350
|
1.950
|
Announcement Date
|
16/04/21
|
12/04/22
|
12/04/23
|
09/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3.145
|
2.83
|
2.923
|
11.1
|
9.743
|
9.825
|
EBITDA
1 |
-0.7543
|
-2.6
|
-6.709
|
-6.638
|
-9.548
|
-8.193
|
EBIT
1 |
-0.761
|
-2.606
|
-6.716
|
-6.653
|
-10.12
|
-9.626
|
Operating Margin
|
-24.2%
|
-92.09%
|
-229.76%
|
-59.93%
|
-103.86%
|
-97.97%
|
Earnings before Tax (EBT)
1 |
-0.761
|
-2.606
|
-6.717
|
-6.653
|
-10.35
|
-9.01
|
Net income
1 |
-0.761
|
-2.606
|
-6.717
|
-6.653
|
-10.35
|
-9.01
|
Net margin
|
-24.2%
|
-92.1%
|
-229.8%
|
-59.93%
|
-106.26%
|
-91.7%
|
EPS
|
-
|
-31.28
|
-0.8506
|
-0.4770
|
-0.3971
|
-0.1616
|
Free Cash Flow
|
-
|
-
|
-5.731
|
-14.95
|
-14.63
|
-35.93
|
FCF margin
|
-
|
-
|
-196.07%
|
-134.7%
|
-150.11%
|
-365.71%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/04/20
|
06/04/20
|
16/04/21
|
12/04/22
|
12/04/23
|
09/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
9.86
|
5.35
|
16.6
|
22.9
|
40.1
|
21.6
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-5.73
|
-15
|
-14.6
|
-35.9
|
ROE (net income / shareholders' equity)
|
-
|
-21.7%
|
-39.2%
|
-20.7%
|
-19.2%
|
-12.3%
|
ROA (Net income/ Total Assets)
|
-
|
-12.4%
|
-22%
|
-11.9%
|
-10.6%
|
-7.46%
|
Assets
1 |
-
|
20.98
|
30.56
|
55.84
|
97.53
|
120.8
|
Book Value Per Share
|
-
|
129.0
|
2.240
|
1.930
|
1.210
|
1.420
|
Cash Flow per Share
|
-
|
64.30
|
1.580
|
1.090
|
0.7200
|
0.3900
|
Capex
|
-
|
-
|
-
|
0.17
|
0.1
|
-
|
Capex / Sales
|
-
|
-
|
-
|
1.54%
|
1.06%
|
-
|
Announcement Date
|
06/04/20
|
06/04/20
|
16/04/21
|
12/04/22
|
12/04/23
|
09/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +2.05% | 1.33Cr | | +75.69% | 1.26TCr | | -24.68% | 734.48Cr | | +6.22% | 660.92Cr | | +12.58% | 538.63Cr | | +26.90% | 453.03Cr | | -21.14% | 390.81Cr | | -22.99% | 290.66Cr | | +47.42% | 236.85Cr | | -0.37% | 200.32Cr |
Medical Equipment
|